Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Oxygen-Dependent Reaction of 6-Hydroxydopamine, 5,6-Dihydroxytryptamine, and Related Compounds with Proteins in Vitro: a Model for Cytotoxicity

A. ROTMAN, J. W. DALY and C. R. CREVELING
Molecular Pharmacology November 1976, 12 (6) 887-899;
A. ROTMAN
Laboratory of Chemistry, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J. W. DALY
Laboratory of Chemistry, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. R. CREVELING
Laboratory of Chemistry, National Institute of Arthritis, Metabolism, and Digestive Diseases, National Institutes of Health, Bethesda, Maryland 20014
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • eLetters
  • PDF
Loading

Abstract

An oxygen-dependent, covalent interaction of radioactive 6-hydroxydopamine, 5,6-dihydroxtryptamine, and related compounds with several model proteins in vitro is described. 6-Hydroxydopamine and 5,6-dihydroxytryptamine react with bovine serum albumin in the presence of oxygen to yield a total of about 12 moles of amine bound per mole of protein. The nature of the oxidation product which reacts rapidly has not been defined, but in the case of 6-hydroxydopamine the amine moiety of the side chain, and hence cyclization to a dihydroxyindole, is not required. 5,7-Dihydroxytryptamine, norepinephrine, and dopamine react much more slowly, and tyramine, serotonin, and nonphenolic amines, not at all. The reaction of 6-hydroxydopamine and 5,6-dihydroxytryptamine appears to occur almost exclusively with sulfhydryl groups of proteins, but both amines appear capable of generating additional free sulfhydryl groups by reduction of disulfide bonds in proteins. Denaturation of proteins such as albumins or hemoglobins with 6 M urea results in a marked increase in the amount of radioactive amine bound per mole of protein. This binding approaches the theoretical number of potential free sulfhydryl groups, suggesting that in the native proteins certain sulfhydryl and/or disulfide bonds are inaccessible to the amine. In proteins which do not contain disulfide bonds, blockade of free sulfhydryl groups with N-ethylmaleimide renders the protein resistant to interaction with 6-hydroxydopamine. Polylysine reacts only slowly with 6-hydroxydopamine. The reaction product of radioactive 6-hydroxydopamine and bovine serum albumin consists primarily not of monomeric protein but of a series of polymeric proteins as determined by gel filtration and polyacrylamide gel electrophoresis. The cross-linking of bovine serum albumin to form polymers which occurred with both 6-hydroxydopamine and 5,6-dihydroxytryptamine was irreversible. Incorporation of more than 2 moles of amine per mole of protein appeared to be required for cross-linking. Acid hydrolysis of 6-hydroxydopamine-cross-linked bovine serum albumin yielded two radioactive, ninhydrin-positive products, which are suggested to be cysteine derivatives. The covalent binding and induction of cross-linking of proteins in vitro by 6-hydroxydopamine and 5,6-dihydroxytryptamine is discussed from a mechanistic standpoint and as a possible model for the mechanism of the cytotoxic actions of these compounds in vivo.

  • Copyright © 1976 by Academic Press, Inc.

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years. 

Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page. 

 

  • Click here for information on institutional subscriptions.
  • Click here for information on individual ASPET membership.

 

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top

In this issue

Molecular Pharmacology
Vol. 12, Issue 6
1 Nov 1976
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Oxygen-Dependent Reaction of 6-Hydroxydopamine, 5,6-Dihydroxytryptamine, and Related Compounds with Proteins in Vitro: a Model for Cytotoxicity
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Oxygen-Dependent Reaction of 6-Hydroxydopamine, 5,6-Dihydroxytryptamine, and Related Compounds with Proteins in Vitro: a Model for Cytotoxicity

A. ROTMAN, J. W. DALY and C. R. CREVELING
Molecular Pharmacology November 1, 1976, 12 (6) 887-899;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Oxygen-Dependent Reaction of 6-Hydroxydopamine, 5,6-Dihydroxytryptamine, and Related Compounds with Proteins in Vitro: a Model for Cytotoxicity

A. ROTMAN, J. W. DALY and C. R. CREVELING
Molecular Pharmacology November 1, 1976, 12 (6) 887-899;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Anti-aromatase activity of exemestane phase II metabolites
  • α-Conotoxin Binding Site on the GABAB Receptor
  • Upacicalcet binds to the amino acid binding site of CaSR
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics